We are thrilled to announce that AUXESIS PHARMA HOLDING AB (publ) has successfully submitted the application for its very first patent featuring the ASA.P formulation. A big thank you to EIP-Patent Office for the outstanding work put into this process.

This milestone is a testament to our dedicated team and their hard work. We look forward to future successes and are grateful for the support we’ve received along the way.

Thanks again to everyone involved for making this journey possible and exciting!